Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $61.08MP/E –Yield –
Nuo Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Nuo Therapeutics's total assets was $2.73M at Sep 30, 2026. For fiscal 2025 it was $1.85M, up 55.2% from the year before. Over ten years it grew -12.6% a year on average. The highest annual figure on record is $56.22M in fiscal 2014.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.85M | +55.2% |
| FY2024 | Dec 31, 2024 | $1.19M | -36.7% |
| FY2023 | Dec 31, 2023 | $1.88M | -38.4% |
| FY2022 | Dec 31, 2022 | $3.05M | +107.9% |
| FY2021 | Dec 31, 2021 | $1.47M | +808.1% |
| FY2020 | Dec 31, 2020 | $161.43K | -41.6% |
| FY2019 | Dec 31, 2019 | $276.55K | -71.7% |
| FY2018 | Dec 31, 2018 | $975.50K | -31.5% |
| FY2017 | Dec 31, 2017 | $1.42M | -89.9% |
| FY2016 | Dec 31, 2016 | $14.06M | +98.7% |
| FY2015 | Dec 31, 2015 | $7.07M | -87.4% |
| FY2014 | Dec 31, 2014 | $56.22M | +21.6% |
| FY2013 | Dec 31, 2013 | $46.25M | +4.3% |
| FY2012 | Dec 31, 2012 | $44.33M | +339.9% |
| FY2011 | Dec 31, 2011 | $10.08M | +13.2% |
| FY2010 | Dec 31, 2010 | $8.90M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.73M | +41.6% |
| Q2 FY2026 | Jun 30, 2026 | $2.63M | +93.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.95M | +69.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.85M | +55.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.93M | +12.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.36M | -4.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.15M | -7.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.19M | -36.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.72M | +7.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.42M | +2.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.24M | -44.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.88M | -38.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.60M | -58.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.39M | -68.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.22M | +109.9% |
| Q4 FY2022 | Dec 31, 2022 | $3.05M | +107.9% |
| Q3 FY2022 | Sep 30, 2022 | $3.86M | +2477.7% |
| Q2 FY2022 | Jun 30, 2022 | $4.32M | +2724.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.06M | +572.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.47M | +808.1% |
| Q3 FY2021 | Sep 30, 2021 | $149.93K | – |
| Q2 FY2021 | Jun 30, 2021 | $153.09K | +1177476.9% |
| Q1 FY2021 | Mar 31, 2021 | $157.26K | +1199.1% |
| Q4 FY2020 | Dec 31, 2020 | $161.43K | -41.6% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $13 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $12.11K | -97.4% |
| Q4 FY2019 | Dec 31, 2019 | $276.55K | -71.7% |
| Q3 FY2019 | Sep 30, 2019 | $38.50K | -94.9% |
| Q2 FY2019 | Jun 30, 2019 | $154.34K | -81.3% |
| Q1 FY2019 | Mar 31, 2019 | $461.40K | -52.6% |
| Q4 FY2018 | Dec 31, 2018 | $975.50K | -31.5% |
| Q3 FY2018 | Sep 30, 2018 | $759.84K | -92.6% |
| Q2 FY2018 | Jun 30, 2018 | $823.33K | -90.7% |
| Q1 FY2018 | Mar 31, 2018 | $972.75K | -92.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.42M | -89.9% |
| Q3 FY2017 | Sep 30, 2017 | $10.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $8.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.06M | – |
See a number that looks wrong?